Upconverting nanoparticles (UCNPs) as a measurement technology enables more sensitive results to your diagnostic assays. Our upcoming biotech company offers these UCNP – particles and readers as a part of its product portfolio. The new company, including three frontrunners in the field, will provide a total solution for point-of-care testing. Anywhere and at any time! Stay tuned for updates.
Labrox already provides a UPCON reader, which is a co-operation project developed with Kaivogen. This UPCON reader was featured in a scientific report that was published recently. You can read about it here.
If you’re interested in upgrading your diagnostics toolkit, contact us by sending us an e-mail to support[at]labrox.fi, and let’s discuss!
Bayoumy, S., Martiskainen, I., Heikkilä, T. et al. Sensitive and quantitative detection of cardiac troponin I with upconverting nanoparticle lateral flow test with minimized interference. Sci Rep 11, 18698 (2021). https://doi.org/10.1038/s41598-021-98199-y